SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-14-003916
Filing Date
2014-08-12
Accepted
2014-08-12 16:17:08
Documents
4
Period of Report
2014-08-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1401539_8k.htm 8-K 14763
2 EXHIBIT 99.1 t1401539_ex99-1.htm EX-99.1 72926
3 GRAPHIC logo.jpg GRAPHIC 11090
4 GRAPHIC logo1.jpg GRAPHIC 4795
  Complete submission text file 0001571049-14-003916.txt   111093
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50626 | Film No.: 141034157
SIC: 2834 Pharmaceutical Preparations